Tests in

Neurodegeneration with Brain Iron Accumulation (NBIA) Sequencing

  • Test Code:
    2101
  • Department:
    Molecular Genetics
  • Test Synonyms:
    NBIA NGS • ATP13A2 • C19orf12 • CIA01 • COASY • CP • DCAF17 • FA2H • FTL • FUCA1 • KIF1A • KMT2B (MLL4) • MECR • PANK2 • PLA2G6 • PSEN1 • REPS1 • SCP2 • SCL39A14 • SQSTM1 • TRIM32 • UBTF • VPS13A • WDR45
View Test

Neuroferritinopathy, FTL, Sequencing

  • Test Code:
    1550
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Neurodegeneration with Brain Iron Accumulation • NBIA • Ferritinopathy • Ferritin Light Chain • FTL1
View Test

Non-Compaction Arrhythmogenic Left Ventricular Cardiomyopathy Panel

  • Test Code:
  • Department:
    Molecular Genetics
  • Test Synonyms:
    LVNC • Intertrabecular Recesses • ACTC1 • ACTN2 • DTNA • LDB3 • LMNA • MYBPC3 • MYH7 • MYL3 • TAZ • TNNT2 • TPM1 • VCL
View Test

Noonan and Other Related Disorders

  • Test Code:
    2135
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Cardiofaciocutaneous syndrome • Costello syndrome • Legius syndrome • Multiple Lentigenes • LEOPARD syndrome • Loose anagen hair (NSLAH) • BRAF • CBL • HRAS • KRAS • MAP2K1 • MAP2K2 • NRAS • PTPN11 • RAF1 • RIT1 • SHOC2 • SOS1 • SPRED1
View Test

NRAS Mutation Analysis

  • Test Code:
    5100
  • Department:
    Solid Tumors
  • Test Synonyms:
    NRAS Gene Mutation (exons 1, 2)
View Test

NSCLC FISH Panel (ALK, RET, ROS1, MET)

  • Test Code:
    7600
  • Department:
    Cancer FISH
  • Test Synonyms:
    Lung Cancer FISH Panel • GeneTrails FISH • NSCLC FISH • ALK • RET • ROS1 • MET
View Test

Nucleophosmin Mutation Testing in Acute Myeloid Leukemia

View Test
Innovations in Testing
View All Tests

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More